Medard Sison, APRN
Psychiatric/Mental Health · Fresno, CANPI 1922507037
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.5% of the total across 419 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 19.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $3,561 and has fallen 53.2% since, to $1,665 in 2025. Among psychiatric/mental health clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 419 payments — averaging $23.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Johnson & Johnson$2K
- Alkermes, Inc.$916
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$804
- Otsuka America Pharmaceutical, Inc.$802
- Neurocrine Biosciences, Inc.$784
- plus $3K from 17 others
What the payments were for
- Food & beverage$9,699100%
- Education$470%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 88 | $1,862 |
| Johnson & Johnson | 56 | $1,674 |
| Alkermes, Inc. | 33 | $916 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 52 | $804 |
| Otsuka America Pharmaceutical, Inc. | 32 | $802 |
| Neurocrine Biosciences, Inc. | 23 | $784 |
| Teva Pharmaceuticals USA, Inc. | 31 | $552 |
| Almatica Pharma LLC | 18 | $461 |
| Indivior Inc. | 17 | $415 |
| Corium, LLC | 12 | $289 |
| Lundbeck LLC | 16 | $286 |
| Vanda Pharmaceuticals Inc. | 8 | $165 |
| Axsome Therapeutics, Inc. | 5 | $141 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $133 |
| Tris Pharma Inc | 6 | $105 |
| Supernus Pharmaceuticals, Inc. | 2 | $79 |
| Biogen | 3 | $73 |
| Tempus AI, Inc | 4 | $72 |
| Sunovion Pharmaceuticals Inc. | 3 | $57 |
| Noven Therapeutics, LLC | 1 | $22 |
| Sun Pharmaceutical Industries Inc. | 1 | $21 |
| Neuronetics, Inc. | 1 | $17 |
| Collegium Pharmaceutical, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INVEGA SUSTENNA$264
- INVEGA TRINZA$264
- REXULTI$125
- VRAYLAR$125
- CAPLYTA$119
How this compares
$9,746 in reported general payments places this provider in the 95th percentile of 2,433 psychiatric/mental health providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxcarbazepine | 27 | $500 |
| Hydroxyzine Hcl | 12 | $216 |
| Bupropion XlBupropion Hcl | 13 | $157 |
| Risperidone | 14 | $138 |
| Lorazepam | 12 | $92 |
| Escitalopram Oxalate | 12 | $62 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Fresno
- Noah SarrFresno$12K
- Carey MartinMillbrae$745K
- Liberty MaciasRedlands$288K
- Joshua BurgettSacramento$239K
- Jovita Ezirim-SalamialofojeLos Angeles$162K
- Angie-Kolleen TanThousand Oaks$159K
- Thy LamVista$121K
- Samantha PerkinsAnaheim$49K
- Yvette ElpidioOrange$43K
- Sarah KoLos Angeles$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.